Priyal Sheth
About Priyal Sheth
Priyal Sheth is the Senior Director of Forecasting and National Analytics at BeiGene in San Mateo, California, with extensive experience in the pharmaceutical and biotech industries.
Title
Priyal Sheth currently holds the position of Senior Director, Forecasting and National Analytics at BeiGene in San Mateo, California, United States.
Company
Throughout her career, Priyal Sheth has worked extensively with BeiGene, taking on roles of increasing responsibility. Currently, she serves as Senior Director, Forecasting and National Analytics. She has also held positions at Adamas Pharmaceuticals, Inc., inVentiv Health Consulting, Merck, Astellas Pharma, and Ambrx Inc.
Education and Expertise
Priyal Sheth holds an MBA in Strategy and Finance from the University of California, Berkeley, Haas School of Business. Additionally, she earned a Masters and a Bachelors in Bioengineering (Biotechnology) from UC San Diego. Her academic background is complemented by extensive experience in various therapy areas including Oncology, Rheumatology, Cardiology, Ophthalmology, Obesity, and Neurology.
Background
Priyal Sheth has built a diverse career spanning several notable pharmaceutical and biotech companies. She has held key roles in market planning, business insights, and forecasting. Her work has involved external opportunity identification, in-licensing, non-personal promotional tactics, and vendor prioritization. She is experienced in congress planning and has led projects involving primary and secondary research, as well as commercialization and launch strategies.
Professional Experience
Priyal Sheth's professional journey includes significant roles at leading companies. She was Associate Director, Market Research and Business Insights at BeiGene before her promotions. At Adamas Pharmaceuticals, Inc., she held positions of Senior Manager and Associate Director of Market Planning. Her prior experience includes a stint as a Management Consultant at inVentiv Health Consulting, as well as scientific roles at Merck and Astellas Pharma.